Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jamal Wadi Al-Ramahi"'
Autor:
Jamal Wadi Al-Ramahi, Rola Ali Ghanem, Omar Helmy Sayyouh, Dima Al-Jammal, Mayar M. Said, Salwa Nasrat, Mona El-Shokry, Mahmoud Gazo, Tamer Saied Osman
Publikováno v:
Microbiology Research, Vol 14, Iss 4, Pp 1559-1567 (2023)
Candida auris (C. auris) is an opportunistic budding yeast that has been identified across 41 countries, including several countries in the Middle East. The increasing global concern stems from the pathogen’s acquired resistance to antifungal drugs
Externí odkaz:
https://doaj.org/article/42187ccc333d4a9bb99debcb0b99cf71
Publikováno v:
Frontiers in Antibiotics, Vol 3 (2024)
ObjectivesTo evaluate the in vitro antimicrobial susceptibilities of Gram-positive and Gram-negative isolates from patients in Jordan between 2010 and 2021, through the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme.MethodsMedica
Externí odkaz:
https://doaj.org/article/63359474c4974eff8a21d4552d0bfe8a
Autor:
Jamal Wadi Al Ramahi, Hassan Annab, Mutaz Al Karmi, Basel Kirresh, Mahmoud Wreikat, Rami Batarseh, Muhannad Yacoub, Mais Kaderi
Publikováno v:
International Journal of Infectious Diseases, Vol 58, Iss C, Pp 77-81 (2017)
Background: Buruli ulcer is the third most common mycobacterial infection worldwide. It is endemic in tropical, subtropical, and temperate climates. It causes devastating disease with morbidity and mortality. The treatment duration is long and the re
Externí odkaz:
https://doaj.org/article/f586c7ba10884d01bd44cb766cabce7d
Publikováno v:
Advances in Infectious Diseases. 12:781-787
Autor:
Jamal Wadi Al Ramahi
Here, we describe two cases of Lophomonas blattarum bronchopulmonary infection. The first patient was diagnosed for long years with chronic lymphocytic leukemia and was stable all through his course. The second patient was an immunocompetent patient.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::c8c8e1dd6d88a992da352197dde30700
https://zenodo.org/record/6786768
https://zenodo.org/record/6786768
Autor:
Jamal Wadi Al Ramahi, Nour Hasan, Amal Matar, Ma'en Maher Al-Ali, Lara Abdulhadi, Dania Abu Kaf, Waseem Saadeh, Nour Hamdan, Hassan AbuKhalaf, Mohamed Gharaibeh, Hanadi Hamadallah, Ala'a Bader, Mohammad Atout, Sae’ed Moh. Mar’I, Tamer Alhamed
Publikováno v:
The International Arabic Journal of Antimicrobial Agents. 12
Background Vitamin D3 (1,25(OH)2 cholecalciferol) as a treatment for COVID 19 patients is being disputed, and a clear clinical benefit is not being confirmed. Methods A retrospective evaluation for COVID-19 patients who were treated with various cumu
Autor:
Ilker Devrim, Hakan Erdem, Amani El-Kholy, Abdullah Almohaizeie, Mateja Logar, Bilal Ahmad Rahimi, Fatma Amer, Sevil Alkan-Ceviker, Meliha Cagla Sonmezer, Maya Belitova, Jamal Wadi Al-Ramahi, Natalia Pshenichnaya, Maha Ali Gad, Lurdes Santos, Reham Khedr, Abdullahi Nur Hassan, Elif Boncuoglu, Andrea Cortegiani, Andrea Marino, Anna Liskova, Atousa Hakamifard, Corneliu Petru Popescu, Mumtaz Ali Khan, Ralitsa Marinova, Nikolaj Petrov, Emmanuel Nsutebu, Ghaydaa Shehata, Hamed Azhdari Tehrani, Handan Alay, Ivana Mareković, Joanna Zajkowska, Aidos Konkayev, Manar Ezzelarab Ramadan, Michele Pagani, Hasan Agin, Pierre Tattevin, Rehab El-Sokkary, Rezaul Karim Ripon, Ricardo Fernandez, Rosa Fontana Del Vecchio, Simona Daniela Popescu, Souha Kanj
Publikováno v:
American Journal of Infection Control
American Journal of Infection Control, 2022, ⟨10.1016/j.ajic.2022.02.031⟩
American Journal of Infection Control, 2022, ⟨10.1016/j.ajic.2022.02.031⟩
International audience; BACKGROUND: Because central line-associated bloodstream infections (CLABSIs) are a significant complication of central venous access, it is critical to prevent CLABSIs through the use of central line bundles. The purpose of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a307b45c2e4164b6cf35e4588c5df8
https://www.bib.irb.hr/1193338
https://www.bib.irb.hr/1193338
Autor:
Jamal Wadi Al Ramahi1,2 jamalwadimd@yahoo.com, Mustafa Ramadan2, Waad Jaber2, Lamya Abushanab3, Mohammad Mughrabi3, Noor Alshamayleh3, Ahmad Mulhem3, Dania Momani1, Mohammad Obaidat3, Ghayda Haddad1, Basma Khalil2, Anas Zahran4, Esraa Odat4, Nadeen Kufoof4, Haneen Arabiat4, Amr Diab2, Anzueto, Antonio5
Publikováno v:
Journal of Infection in Developing Countries. Oct2018, Vol. 12 Issue 10, p878-886. 9p.
Publikováno v:
The International Arabic Journal of Antimicrobial Agents. 10
Background To assess the rates and trends of resistance among ESKAPE pathogens during 2010 – 2019. Methods A retrospective, single-center study between 2010 –2019, non-duplicate isolates from six sterile sources were studied. Pathogens were proce
Autor:
Dania Abu Kaf, Jamal Wadi Al Ramahi, Waseem Saadeh, Nour Hamdan, Nour Hasan, Hanadi Hamadallah, Amal Matar, Lara Abdulhadi, Mohammad Atout, Ala'a Bader, Tamer Alhamed, Sae’ed Moh Mar’I, Mohamed Gharaibeh, Ma'en Maher Al-Ali
Publikováno v:
International Journal of Infectious Diseases and Therapy. 6:146
Studies disputed the use of tocilizumab in the treatment of COVID-19 patients, retrospective studies and one interventional study from the RECOVER study supported tocilizumab use, however, many other interventional and a retrospective propensity scor